drugset / Trial / NCT01892813

Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers

NCT01892813

RandomizedParallel-groupDouble-blindTreatment

Summary

The project is designed to examine the effectiveness of strategies to increase access to treatment for tobacco use and dependence among rural Veteran smokers. In addition, it will examine whether tailored treatment that is designed to address common comorbid conditions that are related to cigarette smoking enhances success with quitting relative to enhanced standard of care. The investigators hypothesize that participants assigned to the tailored tobacco cessation intervention will report greater cessation rates at six months. The investigators also anticipate more favorable outcomes on measures of depressive symptoms, alcohol use, and body weight.

Timeline

Start
2013-07
Primary completion
2018-01
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Background Bupropion Small molecule
Background Nicotine Unknown
Background Varenicline Small molecule

Indications